Characteristics and Outcomes in Cases of US Male Patients with Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice

INTRODUCTION: Breast cancer in males constitutes approximately 1% of all breast cancer cases globally. Despite extensive treatment experience with abemaciclib in women with metastatic breast cancer (MBC), real-world evidence in male MBC is lacking. METHODS: This analysis was a part of a broader, ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Ring, Alistair, Karuturi, Meghan, Smyth, Emily Nash, Lokhandwala, Tasneem, Sheffield, Kristin M., Willey, Joanne, Lunacsek, Orsolya, Sapunar, Francisco, Cui, Zhanglin Lin, Coutinho, Anna, Rybowski, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129913/
https://www.ncbi.nlm.nih.gov/pubmed/36995468
http://dx.doi.org/10.1007/s12325-023-02471-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129913/
https://www.ncbi.nlm.nih.gov/pubmed/36995468
http://dx.doi.org/10.1007/s12325-023-02471-8

Ejemplares similares